A B-cell lymphoma case that is unclassifiable, and intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma of lacrimal gland

Tatsuya Yunoki*, Jun Murakami, Yukihiro Imagawa, Takahiko Nakajima, Atsushi Hayashi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 60-year-old woman presented with acute eyelid swelling and a subcutaneous hemorrhage in the right eye. Magnetic resonance imaging showed a spherical tumor of the lacrimal gland. The tumor was removed by the Kroenlein method. We diagnosed as a B-cell lymphoma that is unclassifiable, and intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) (intermediate DLBCL/BL) based on its immunohistopathological examination and c-MYC/IgH rearrangement. We administered six cycles of dose-adjusted- EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin hydrochloride, and rituximab) therapy, and remission of the lymphoma was obtained. This is the first case of an intermediate DLBCL/BL of a lacrimal gland.

Original languageEnglish
Pages (from-to)31-33
Number of pages3
JournalInternational Medical Case Reports Journal
Volume10
DOIs
StatePublished - 2017/02/01

Keywords

  • Burkitt lymphoma
  • C-MYC gene
  • Diffuse large B-cell lymphoma
  • Fluorescence in situ hybridization

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'A B-cell lymphoma case that is unclassifiable, and intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma of lacrimal gland'. Together they form a unique fingerprint.

Cite this